Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (9243)	6/5/1998 5:24:00 PM
From: g.w. barnard	Read Replies (2) \| Respond to of 23519

v, get this from: "Harvard Scientific Achieves Another Milestone as Management Predicts Product Success" "Thomas E. Waite, the Company's President and CEO stated, "over the last couple of months we have experienced an extreme shake-out in the sexual dysfunction product market due to Pfizer's introduction of Viagra. Vivus's and Pharmacia's sales have plummeted and their market presence is almost non-existent. This could obviously be catastrophic to a corporation, especially to Vivus which currently relies on only one product (MUSE(R)) for its sales." This is what leland better address in his morning conference. I have taken the liberty to send this to nina. gw